TD Cowen Reiterates Buy Rating on Eli Lilly (LLY) Post US Government Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Freedom Capital Markets Downgrades Eli Lilly (LLY) to Hold
November 10, 2025 9:13 AM ESTFreedom Capital Markets analyst Ilya Zubkov downgraded Eli Lilly (NYSE: LLY) from Buy to Hold with a price target of $950.00 (from $750.00).
The analyst comments "Eli Lilly delivered one of the strongest quarters in its history, with revenue rising 54% year-over-year to $17.6 billionwell above the analyst consensus of $16.0 billion. Adjusted EPS... More
